These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34766056)

  • 1. Insight from nanomaterials and nanotechnology towards COVID-19.
    Singh YD; Ningthoujam R; Panda MK; Jena B; Babu PJ; Mishra AK
    Sens Int; 2021; 2():100099. PubMed ID: 34766056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic.
    Weiss C; Carriere M; Fusco L; Capua I; Regla-Nava JA; Pasquali M; Scott JA; Vitale F; Unal MA; Mattevi C; Bedognetti D; Merkoçi A; Tasciotti E; Yilmazer A; Gogotsi Y; Stellacci F; Delogu LG
    ACS Nano; 2020 Jun; 14(6):6383-6406. PubMed ID: 32519842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology-Based Approach to Combat Pandemic COVID 19: A Review.
    Shukla BK; Tyagi H; Bhandari H; Garg S
    Macromol Symp; 2021 Jun; 397(1):2000336. PubMed ID: 34511843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology: an emerging approach to combat COVID-19.
    Chintagunta AD; M SK; Nalluru S; N S SK
    Emergent Mater; 2021; 4(1):119-130. PubMed ID: 33615141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints.
    Rai M; Bonde S; Yadav A; Plekhanova Y; Reshetilov A; Gupta I; Golińska P; Pandit R; Ingle AP
    Expert Rev Anti Infect Ther; 2022 Oct; 20(10):1299-1308. PubMed ID: 33164589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Nanotechnology and Materials Science Help the Fight against SARS-CoV-2?
    Sportelli MC; Izzi M; Kukushkina EA; Hossain SI; Picca RA; Ditaranto N; Cioffi N
    Nanomaterials (Basel); 2020 Apr; 10(4):. PubMed ID: 32326343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology and COVID-19 Convergence: Toward New Planetary Health Interventions Against the Pandemic.
    Sahoo P; Dey J; Mahapatra SR; Ghosh A; Jaiswal A; Padhi S; Prabhuswamimath SC; Misra N; Suar M
    OMICS; 2022 Sep; 26(9):473-488. PubMed ID: 36040392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights from nanotechnology in COVID-19: prevention, detection, therapy and immunomodulation.
    Singh P; Singh D; Sa P; Mohapatra P; Khuntia A; K Sahoo S
    Nanomedicine (Lond); 2021 Jun; 16(14):1219-1235. PubMed ID: 33998837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
    Gudadappanavar AM; Benni J
    J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology Responses to COVID-19.
    Ruiz-Hitzky E; Darder M; Wicklein B; Ruiz-Garcia C; Martín-Sampedro R; Del Real G; Aranda P
    Adv Healthc Mater; 2020 Oct; 9(19):e2000979. PubMed ID: 32885616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-COVID-19 Nanomaterials: Directions to Improve Prevention, Diagnosis, and Treatment.
    Souri M; Chiani M; Farhangi A; Mehrabi MR; Nourouzian D; Raahemifar K; Soltani M
    Nanomaterials (Basel); 2022 Feb; 12(5):. PubMed ID: 35269270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the application of graphene oxide contribute to the fight against COVID-19? Antiviral activity, diagnosis and prevention.
    Rhazouani A; Aziz K; Gamrani H; Gebrati L; Uddin MS; Faissal A
    Curr Res Pharmacol Drug Discov; 2021; 2():100062. PubMed ID: 34870157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanotechnology for the management of COVID-19 during the pandemic and in the post-pandemic era.
    Xu C; Lei C; Hosseinpour S; Ivanovski S; Walsh LJ; Khademhosseini A
    Natl Sci Rev; 2022 Oct; 9(10):nwac124. PubMed ID: 36196115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of nanomaterials in COVID-19 pandemic.
    Xiao MF; Zeng C; Li SH; Yuan FL
    Rare Metals; 2022; 41(1):1-13. PubMed ID: 34539132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of the use of biomaterials, nanotechnology, and stem cells for detection and treatment of COVID-19: towards a framework to address future global pandemics.
    Ghaffari M; Mollazadeh-Bajestani M; Moztarzadeh F; Uludağ H; Hardy JG; Mozafari M
    Emergent Mater; 2021; 4(1):19-34. PubMed ID: 33426467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pipeline Pharmacological Therapies in Clinical Trial for COVID-19 Pandemic: a Recent Update.
    Kumari P; Rawat K; Saha L
    Curr Pharmacol Rep; 2020; 6(5):228-240. PubMed ID: 32837854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can nanotechnology help in the fight against COVID-19?
    Palestino G; García-Silva I; González-Ortega O; Rosales-Mendoza S
    Expert Rev Anti Infect Ther; 2020 Sep; 18(9):849-864. PubMed ID: 32574081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outbreak of COVID-19: A Detailed Overview and Its Consequences.
    Shivalkar S; Pingali MS; Verma A; Singh A; Singh V; Paital B; Das D; Varadwaj PK; Samanta SK
    Adv Exp Med Biol; 2021; 1353():23-45. PubMed ID: 35137366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.